Sun Pharma hits 16-month low
In past three trading sessions, the stock has declined 5% as compared to 1% rise in the S&P BSE Sensex.23-11-2015
23-11-2015
Analysts blow cold at Sun Pharma move
Taro, affiliates to invest in US wind energy project but critics rap proposal as non-optimal use of cash21-11-2015
Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
Sudhir Vrundavandas Valia has submitted the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSE20-11-2015
Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
Sudhir V Valia has submitted the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSE18-11-2015
Sun Pharma Eyes Expansion of Global Consumer Healthcare Space
Pharmaceutical major Sun Pharma is looking to expand its business in the global consumer healthcare space and is not averse to acquiring new brands, a top company executive said on Tuesday.17-11-2015
Sun Pharma gains 2%; BofA ML sets target at Rs 1,070
BofA-ML said, "The potential upside for the stock could be over 40 per cent if the Halol issue does not escalate."17-11-2015
Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
Virtuous Finance Pvt Ltd has submitted the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSE16-11-2015
Sun Pharma in talks with Novartis for acquiring Japan business
According to sources, the deal could be valued at $300-400 mn and may be concluded as early as December13-11-2015
Sun Pharma Q2 net profit falls 46% to Rs1,107 crore
MD Dilip Shanghvi says Sun Pharmas performance hurt by lower sales, volatile currency movements and supply constraints07-11-2015
Announces Q2 results, Limited Review Report & Results Press Release for the Quarter ended September 30, 2015
Sun Pharmaceutical Industries Ltd has announced the following results for the quarter ended September 30, 2015 :The Un-Audited Standalone results for the Quarter ended September 30, 2015:The Company has posted a net loss of Rs. (6013.20) million for the quarter ended September 30, 2015 as compared to net loss of Rs. (6859.00) million for the quarter ended September 30, 2014. Total Income has decreased from Rs. 17892.90 million for...07-11-2015